Immune checkpoint inhibitors: a new landscape for extensive stage small cell lung cancer treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune checkpoint inhibitors: a new landscape for extensive stage small cell lung cancer treatment

Published:2021-08-23 Issue:11 Volume:15 Page:1415-1425
ISSN:1747-6348
Container-title:Expert Review of Respiratory Medicine
language:en
Short-container-title:Expert Review of Respiratory Medicine

Author:

Bianco Andrea¹²^ORCID,D’Agnano Vito¹²,Matera Maria Gabriella³,Della Gravara Luigi²,Perrotta Fabio¹,Rocco Danilo²

Affiliation:

1. Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, Napoli, Italy

2. Department of Pneumology and Oncology- A.o Dei Colli - Monaldi Hospital, Napoli, Italy

3. Department of Experimental Medicine, University of Campania “Luigi Vanvitelli”, Napoli, Italy

Publisher

Informa UK Limited

Subject

Public Health, Environmental and Occupational Health,Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/17476348.2021.1964362

Reference102 articles.

1. Non-Small Cell Lung Cancer: Epidemiology, Risk Factors, Treatment, and Survivorship

2. Pembrolizumab in Patients With Extensive-Stage Small-Cell Lung Cancer: Results From the Phase Ib KEYNOTE-028 Study

3. Survival changes in patients with small cell lung cancer and disparities between different sexes, socioeconomic statuses and ages

4. Trends in incidence of small cell lung cancer and all lung cancer

5. Current views on molecularly targeted therapy for lung cancer – a review of literature from the last five years

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diagnostic Accuracy of Ultrasound Guided Percutaneous Pleural Needle Biopsy for Malignant Pleural Mesothelioma;Journal of Clinical Medicine;2024-04-29

2. Comorbidities in COPD: Current and Future Treatment Challenges;Journal of Clinical Medicine;2024-01-27

3. Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide;Lung Cancer;2023-12

4. Current challenges and perspectives in lung cancer care during COVID-19 waves;Current Opinion in Pulmonary Medicine;2023-05-02

5. Combining PD-1 or PD-L1 inhibitors with chemotherapy is a good strategy for the treatment of extensive small cell lung cancer: A retrospective analysis of clinical studies;Frontiers in Immunology;2022-12-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3